Blog | Trial Flow

From patient support to trial impact: Why the pathway matters

Written by Trial Flow | Nov 12, 2026, 2:24:55 PM
Supporting retention through participant readiness

Clinical trials ask a lot of participants. They ask people to understand complex information, attend scheduled visits, follow protocol requirements, manage uncertainty, and continue engaging over time. 

For caregivers, the work can be even broader: organizing appointments, supporting decisions, managing anxiety, explaining the study to a child or family member, and fitting trial activities around daily life. 

Patient support is intended to make that work easier. But support only has value if it is linked to a clear purpose. More information, more reminders or more digital content will not automatically help participants feel prepared, stay engaged or remain in a study. 

The important issue is what patient support is expected to influence, and how those changes may contribute to study delivery. The challenge is not simply providing support. It is ensuring participants are ready to take part throughout the study journey. Trial Flow describes this as participant readiness: the combination of understanding, confidence, preparation and ongoing engagement needed to support participation over time. 

Support needs a clear pathway 

Sponsors and CROs are often focused on outcomes such as adherence, retention, data completeness and trial timelines. These outcomes matter because they affect study delivery, operational cost, evidence quality and confidence in the results. 

Many of these outcomes appear late in the trial journey. 

By the time a participant misses a visit, disengages or leaves the study, the underlying support need may have been present for some time. They may not have understood what was expected. They may have felt anxious about a procedure, struggled with travel or competing responsibilities, or lost connection with the purpose of the study between visits. 

This is why patient support needs to be designed as part of a delivery pathway, rather than treated as a set of standalone materials. The question is, what support needs to change for participants, at which point in the journey, and how those changes may reduce avoidable risks to engagement, adherence and retention. 

What a Theory of Change and Retention ROI Model adds 

For patient support to deliver value, there needs to be a clear understanding of how it is expected to influence trial participation. 

Sponsors and CROs often invest in support because they want to improve outcomes such as adherence, retention, data completeness and study delivery. The challenge is that these outcomes occur later in the patient journey and are influenced by many different factors. 

A Theory of Change and Retention ROI Model helps bridge that gap. 

It provides a structured way of explaining how patient support is expected to contribute to meaningful change. Rather than focusing only on the support being provided, it focuses on what needs to change for participants, why those changes matter, and how they may contribute to trial delivery outcomes. 

In clinical trials, patient support is a complex intervention. It may include educational content, reminders, preparation guidance, emotional support, practical planning tools and ongoing engagement activities, delivered at different points throughout the study journey. A Theory of Change and Retention ROI Model helps clarify the role of each component and how they work together. 

It also makes underlying assumptions more explicit. For support to be effective, participants need to be able to access it, trust it, understand it and use it at the right time. Support must also be relevant to the demands of the protocol and integrated into the patient experience in a way that feels useful rather than burdensome. 

Without this evidence logic, patient support can become a collection of well-intentioned resources that are difficult to evaluate and not clearly connected to the barriers participants face. A Theory of Change and ROI Model creates a clearer pathway between support activities, patient experience and the outcomes that matter for study delivery. 

Participant readiness as the central pathway 

For Trial Flow, the Theory of Change is centred on participant readiness.  

Readiness describes whether participants are prepared and able to take part in study activities over time. It sits between the support participants receive and the trial outcomes sponsors and CROs care about. 

In the simplified version of Trial Flow’s model, the pathway is: 

Patient support → participant readiness → trial impact 

This blog series uses a simplified version of Trial Flow’s full Theory of Change and Retention ROI Model. The full whitepaper sets out the detailed framework behind the model, including behavioral mechanisms, preparedness components, assumptions, early participant indicators and evaluation measures. 

The simplified model has three layers. 

1. Patient support 

Patient support includes the four preparedness components that participants may need across the study: 

  • Educational support: information and understanding

  • Emotional support: confidence and coping

  • Logistical support: planning and coordination

  • Motivational support: progress and encouragement 

Different studies will place different demands on participants. A complex procedure, long follow-up period, high visit burden or caregiver-dependent population may each require a different balance of support. For example, a participant preparing for a complex procedure may need educational support to understand what will happen, emotional support to manage anxiety, logistical support to prepare correctly for the visit, and motivational support to stay engaged between visits. 

2. Participant readiness 

Patient support is expected to contribute to earlier signs that participants are prepared and able to continue. These include: 

  • Preparedness: participants are prepared and able to take part across their trial journey

  • Engagement: participants continue interacting with relevant support across the study

  • Adherence: participants stay on track with study requirements 

These are not the same as retention. They are earlier signals that help study teams understand whether participants may be prepared, supported and able to continue.

3. Trial impact 

Over time, stronger participant readiness may contribute to outcomes that matter for study delivery: 

  • Retention: participants remain in the study

  • Acceleration: avoidable delays and disruption may be reduced

  • Study visibility: teams can better understand engagement through in-app behaviors and usage metrics 

These signals do not prove retention impact on their own. They form part of a wider evidence pathway that helps sponsors and CROs evaluate whether support is being used as intended and whether it may be reducing avoidable participation risks. 

Why this matters for sponsors and CROs 

Patient support is often discussed as part of patient experience. That is important, but it is only part of the value. 

For study teams, patient support is also linked to trial delivery risk. When participants are not adequately supported, the consequences can appear as missed visits, protocol deviations, incomplete data, additional site follow-up, avoidable delays and limited visibility of patient needs between study touchpoints. 

Trial Flow’s Theory of Change and Retention ROI Model gives patient support a clearer evidence structure. It links support components to participant readiness and trial impact, so support can be configured around the demands of each study and evaluated through earlier signals before retention risk becomes visible. 

This helps sponsors and CROs move beyond generic participant-facing content. Support can be specific to the protocol, delivered at the right points in the study, and measurable enough to show whether participants are becoming more prepared, engaged and able to stay on track. 

A theory-led support model can also help delivery teams configure support more precisely, focus resources where patient burden is highest and gain earlier visibility into engagement risks before they affect study outcomes. 

Trial Flow’s digital patient support is designed around that logic. It uses a theory-led, protocol-aligned model to support readiness in ways that can be configured, monitored and evaluated. 

The rest of this blog series will explore that pathway in more detail: 

  • Why participants need more than information

  • How behavior-led support can influence participation

  • How earlier indicators can make participant-related trial risk more visible  

Download the full Trial Flow Theory of Change and Retention ROI Model whitepaper to see how participant readiness can be defined, measured and linked to trial delivery outcomes.